中国天楹(000035.SZ)拟回购8000万元-1.6亿元股份 回购价不超4.5元/股
格隆汇2月4日丨中国天楹(000035.SZ)发布回购公司股份方案,本次回购股份的种类为公司发行的人民币普通股(A股),回购的资金总额不低于人民币8000万元(含),不超过人民币1.6亿元(含),回购股份价格不超过人民币4.50元/股(含),若按回购金额上限、回购价格上限测算,预计可回购股份数量约为3556万股,约占公司总股本的1.41%;若按回购金额下限、回购价格上限测算,预计可回购股份数量约为1778万股,约占公司总股本的0.70%,具体回购股份的金额及数量以回购期满时实际回购的金额及股份数量为准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.